Galapagos NV
GLPG
#5171
Rank
C$2.59 B
Marketcap
C$38.64
Share price
0.00%
Change (1 day)
-10.95%
Change (1 year)

Galapagos NV (GLPG) - Total debt

Total debt on the balance sheet as of March 2026 : C$10.37 Million

According to Galapagos NV's latest financial reports the company's total debt is C$10.37 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Galapagos NV - Total debt on balance sheet (from 2008 to 2026)

Total debt by year

Year Total debt Change
2024-12-31C$17.5 M24.41%
2023-12-31C$14.06 M-55.86%
2022-12-31C$31.87 M-17.77%
2021-12-31C$38.76 M-16.03%
2020-12-31C$46.16 M24.3%
2019-12-31C$37.13 M
2018-12-31N/A-100%
2017-12-31C$0.01 M-84.75%
2016-12-31C$0.08 M-48.95%
2015-12-31C$0.17 M-26%
2014-12-31C$0.23 M-59.2%
2013-12-31C$0.57 M8.45%
2012-12-31C$0.53 M-53.96%
2011-12-31C$1.15 M-30.09%
2010-12-31C$1.65 M-26.01%
2009-12-31C$2.23 M-21.94%
2008-12-31C$2.86 M-54.96%
2007-12-31C$6.36 M-46.68%
2006-12-31C$11.93 M8.6%
2005-12-31C$10.98 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
C$76.61 B 738,178.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$47.43 B 457,029.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$101.51 B 978,122.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$32.28 B 311,026.48%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$68.43 B 659,365.63%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$47.25 B 455,297.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$35.16 B 338,734.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
C$74.71 M 620.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$23.55 B 226,900.54%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel